|Articles|June 1, 2016
- Pharmaceutical Executive-06-01-2016
- Volume 36
- Issue 6
Pharmaceutical Executive, June 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Pharm Exec's Top 50 Companies 2016about 10 years ago
Diversity and Inclusion: A Pharma 50 Perspectiveabout 10 years ago
Market Access in Europe: Building Health Equity Through Better Outcomesabout 10 years ago
Design that Deliversabout 10 years ago
A Digital Prescription for the Pharma Industryabout 10 years ago
Science Meets Art: Mapping the Topography of MSabout 10 years ago
Pharma and Biotech Financial Outlook: Hazyabout 10 years ago
Promises and Pitfalls in Calculating Drug Valueabout 10 years ago
Europe’s ‘Radical’ Regulators Drawn Further into Pricing Debateabout 10 years ago
Country Report: ItalyAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
3
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
4
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
5